SCHEMBL3467103

SCHEMBL3467103

Cc1ccc(NS(=O)(=O)c2cccc(CCCC(CCc3ccc(-c4cccc(C#N)c4)cc3)C(=O)O)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 2/20 0.46
MMP12 P39900 1/20 0.46
ADAMTS4 O75173 2/20 0.44
ACLY P53396 2/20 0.42
FFAR1 O14842 1/20 0.42
PGR P06401 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
PTGES2 Q9H7Z7 1/20 0.40
NAMPT P43490 1/20 0.40
HSD17B1 P14061 1/20 0.40
HSD17B2 P37059 1/20 0.40
SGK1 O00141 1/20 0.40
FOLH1 Q04609 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
PTPN2 P17706 2/20 0.39
PTPN1 P18031 2/20 0.39
STAT3 P40763 1/20 0.39
PTPRS Q13332 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3467248 0.88 MMP13 (0.51) MMP13MMP12ADAMTS4ACLYPGR
SCHEMBL8037792 0.86 HTR6 (0.51) PGRALDH1A1NAMPTHDAC8
SCHEMBL1856441 0.84 HTR6 (0.53) PGRALDH1A1NAMPTHDAC8
SCHEMBL7932591 0.82 MMP12 (0.63) MMP13MMP12ADAMTS4FFAR1MMP2
SCHEMBL7928277 0.81 MMP12 (0.64) MMP13MMP12ADAMTS4FFAR1MMP2
SCHEMBL8039484 0.80 HTR6 (0.58) MMP2MMP3NAMPTHDAC8
SCHEMBL1855593 0.78 HTR6 (0.54) ALDH1A1MMP2MMP3
SCHEMBL3467017 0.76 MMP12 (0.57) MMP13MMP12ADAMTS4FFAR1MMP2
SCHEMBL1855764 0.76 MMP2 (0.46) MMP13PGRALDH1A1MMP2MMP3
SCHEMBL3469957 0.76 PTPN2 (0.40) MMP13MMP12ADAMTS4ACLYFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO claimed
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO disclosed
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO disclosed